1   /   4 >
21/11/2017 Sumitomo Dainippon Pharma and Angelini announce partnership for commercialization of Latuda ® (Lurasidone Hydrocloride) in Europe
18/04/2016 Angelini confirms commitment in Infection Control and Infectious Diseases Area
15/02/2016 Angelini announces the launch on the Italian market of an innovative active wound cleanser developed by the Swiss company APR
28/11/2014 The project “Psychè” is set up in order to train the family doctor
04/11/2014 The project La Scuola Angelini - Imparare fa bene is launched at the children’s hospital “Ospedale Pediatrico Bambino Gesù” in Rome
      1   /   4 >
  •  | 
  • 1
  •  | 
  • 2
  •  | 
  • 3
  •  | 
  • ...
  •  | 
  • >
  •  | 
  •  »